Remove Clinical Trials Remove Food Remove Treatment
article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Consider it a testament to the ubiquity and flexibility of the endocannabinoid system: we can inhale medicinal cannabinoids via combustion or vaporization; ingest them via food or drink; and absorb them directly through the skin, the bodys largest organ. New clinical trials are urgently needed, they repeat in a familiar refrain.

article thumbnail

Medical Cannabis and Anxiety: Natural Treatment Options

Miss Marijuana

Clinical trials have been looking into both THC and CBD and their individual roles in treating anxiety. It’s always a good idea to talk to a healthcare professional before switching up your treatment plan. Finding the right cannabis treatment for your anxiety doesn’t have to be complicated. But high doses? The takeaway?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabinoids and Inflammation: The Complete Guide

Miss Marijuana

It can happen because of injuries, infections, or even things like stress and unhealthy food. That means, one day, you might get a treatment made just for you! Personalized Medicine and New Treatments Doctors and scientists are hoping to use cannabinoids in more personalized ways. Pretty cool, right?

article thumbnail

FDA Approves Ketamine Nasal Spray as First and Only Standalone Therapy for Treatment-Resistant Depression

Veriheal

In January, the US Food and Drug Administration (FDA) approved the Johnson & Johnson brand nasal spray, Spravato®, as the world’s first and only monotherapy for addressing treatment-resistant cases of major depressive disorder (MDD). However, doctors do not consider esketamine a first-line treatment for depression.

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Federal health regulators recently declined to approve the use of the psychedelic drug midomafetamine (3,4-methylenedioxymethamphetamine or MDMA) as a treatment for post-traumatic stress disorder (PTSD), disappointing many advocates who were hopeful for the next breakthrough in the psychedelic therapy movement.

article thumbnail

FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial

Cannabis Law Report

Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. TORONTO–(BUSINESS WIRE)–FSD Pharma Inc.

article thumbnail

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.